Literature DB >> 11819715

Follow-up study of hepatitis C virus infection in uremic patients on maintenance hemodialysis for 30 months.

Nian-Song Wang, Lu-Tan Liao, Yan-Juan Zhu, Wei Pan, Fang Fang.   

Abstract

Entities:  

Year:  2000        PMID： 11819715      PMCID： PMC4728281          DOI： 10.3748/wjg.v6.i6.888

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  36 in total

1.  Transmission of anti-HCV within the household of haemodialysis patients.

Authors:  G Calabrese; G Vagelli; R Guaschino; M Gonella
Journal:  Lancet       Date:  1991-12-07       Impact factor: 79.321

Review 2.  Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease.

Authors:  M Houghton; A Weiner; J Han; G Kuo; Q L Choo
Journal:  Hepatology       Date:  1991-08       Impact factor: 17.425

3.  Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States.

Authors:  M J Alter; M S Favero; J E Maynard
Journal:  J Infect Dis       Date:  1986-06       Impact factor: 5.226

4.  Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study.

Authors:  F Fabrizi; G Lunghi; I Guarnori; L Raffaele; S Di Filippo; G Erba; A Pagano; F Locatelli
Journal:  Clin Nephrol       Date:  1995-07       Impact factor: 0.975

5.  The effect of chemical and heat disinfection of the hemodialysis machines on the spread of hepatitis C virus infection: a prospective study.

Authors:  H Abu-Aisha; A Mitwalli; S O Huraib; J Al-Wakeel; J Abid; K I Yousif; F Algayyar; S Ramia
Journal:  Saudi J Kidney Dis Transpl       Date:  1995 April-June

6.  Hepatitis C virus infection: an update.

Authors:  F Z Al-Faleh
Journal:  Saudi J Kidney Dis Transpl       Date:  1995 April-June

7.  Prevalence of hepatitis C virus infection in hemodialysis patients in Sudan.

Authors:  S M Suliman; S Fessaha; M El Sadig; M B El-Hadi; S Lambert; H Fields; H W Ghalib
Journal:  Saudi J Kidney Dis Transpl       Date:  1995 April-June

8.  Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group.

Authors:  N N Zein; J Rakela; E L Krawitt; K R Reddy; T Tominaga; D H Persing
Journal:  Ann Intern Med       Date:  1996-10-15       Impact factor: 25.391

9.  The declining risk of post-transfusion hepatitis C virus infection.

Authors:  J G Donahue; A Muñoz; P M Ness; D E Brown; D H Yawn; H A McAllister; B A Reitz; K E Nelson
Journal:  N Engl J Med       Date:  1992-08-06       Impact factor: 91.245

10.  Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays.

Authors:  T M Chan; A S Lok; I K Cheng; R T Chan
Journal:  Hepatology       Date:  1993-01       Impact factor: 17.425
View more
  4 in total

1.  High frequencies of HGV and TTV infections in blood donors in Hangzhou.

Authors:  J Yan; L L Chen; Y H Luo; Y F Mao; M He
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

2.  Investigation of HGV and TTV infection in sera and saliva from non-hepatitis patients with oral diseases.

Authors:  Jie Yan; Li-Li Chen; Yong-Liang Lou; Xiao-Zhi Zhong
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

3.  Preparation of human single chain Fv antibody against hepatitis C virus E2 protein and its identification in immunohistochemistry.

Authors:  Yan-Wei Zhong; Jun Cheng; Gang Wang; Shuang-Shuang Shi; Li Li; Ling-Xia Zhang; Ju-Mei Chen
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

4.  Novel evolved immunoglobulin (Ig)-binding molecules enhance the detection of IgM against hepatitis C virus.

Authors:  Jie Cao; Qiuli Chen; Huaqun Zhang; Peipei Qi; Chao Liu; Xufang Yang; Niansong Wang; Baohua Qian; Jinhong Wang; Shaohua Jiang; Hua Yang; Shuhan Sun; Wei Pan
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.